Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6506068 [patent_doc_number] => 20100216115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS' [patent_app_type] => utility [patent_app_number] => 12/644883 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17721 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216115.pdf [firstpage_image] =>[orig_patent_app_number] => 12644883 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/644883
METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS Dec 21, 2009 Abandoned
Array ( [id] => 6231436 [patent_doc_number] => 20100184671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Binding molecules for the treatment of myeloid cell malignancies' [patent_app_type] => utility [patent_app_number] => 12/653779 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 28247 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184671.pdf [firstpage_image] =>[orig_patent_app_number] => 12653779 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/653779
Binding molecules for the treatment of myeloid cell malignancies Dec 17, 2009 Issued
Array ( [id] => 6425948 [patent_doc_number] => 20100151501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'Forms of Prostate Specific Antigens and Methods for their Detection' [patent_app_type] => utility [patent_app_number] => 12/632640 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15687 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151501.pdf [firstpage_image] =>[orig_patent_app_number] => 12632640 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/632640
Forms of Prostate Specific Antigens and Methods for their Detection Dec 6, 2009 Abandoned
Array ( [id] => 6436558 [patent_doc_number] => 20100143927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Methods and Assays for Measuring p95 and/or p95 in a Sample and Antibodies Specific for p95' [patent_app_type] => utility [patent_app_number] => 12/629037 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 28805 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143927.pdf [firstpage_image] =>[orig_patent_app_number] => 12629037 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/629037
Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95 Nov 30, 2009 Issued
Array ( [id] => 6356512 [patent_doc_number] => 20100086985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 205P1B5 USEFUL IN TREATMENT AND DETECTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/627998 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 69338 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086985.pdf [firstpage_image] =>[orig_patent_app_number] => 12627998 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/627998
NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 205P1B5 USEFUL IN TREATMENT AND DETECTION OF CANCER Nov 29, 2009 Abandoned
Array ( [id] => 6270884 [patent_doc_number] => 20100255006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'NOVEL MOLECULES OF THE PYRIN/NBS/LRR PROTEIN FAMILY AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/627191 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 64480 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255006.pdf [firstpage_image] =>[orig_patent_app_number] => 12627191 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/627191
NOVEL MOLECULES OF THE PYRIN/NBS/LRR PROTEIN FAMILY AND USES THEREOF Nov 29, 2009 Abandoned
Array ( [id] => 6436549 [patent_doc_number] => 20100143926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Classification of Patients Having Diffuse Large B-cell Lymphoma Based upon Gene Expression' [patent_app_type] => utility [patent_app_number] => 12/625523 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7368 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143926.pdf [firstpage_image] =>[orig_patent_app_number] => 12625523 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/625523
Classification of Patients Having Diffuse Large B-cell Lymphoma Based upon Gene Expression Nov 23, 2009 Abandoned
Array ( [id] => 8625157 [patent_doc_number] => 08357652 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-22 [patent_title] => 'Anti-tumor fibrillar human serum albumin methods and compositions' [patent_app_type] => utility [patent_app_number] => 12/623162 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 7713 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12623162 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/623162
Anti-tumor fibrillar human serum albumin methods and compositions Nov 19, 2009 Issued
Array ( [id] => 6314312 [patent_doc_number] => 20100111969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'IL-4 RECEPTOR AND IL-13 AS PROGNOSTIC MARKERS FOR COLON AND PANCREAS TUMORS' [patent_app_type] => utility [patent_app_number] => 12/609309 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7697 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111969.pdf [firstpage_image] =>[orig_patent_app_number] => 12609309 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/609309
IL-4 RECEPTOR AND IL-13 AS PROGNOSTIC MARKERS FOR COLON AND PANCREAS TUMORS Oct 29, 2009 Abandoned
Array ( [id] => 9046990 [patent_doc_number] => 08541544 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Molecular marker for cancer stem cell' [patent_app_type] => utility [patent_app_number] => 13/126039 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 34 [patent_no_of_words] => 15515 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126039 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/126039
Molecular marker for cancer stem cell Oct 26, 2009 Issued
Array ( [id] => 6430655 [patent_doc_number] => 20100152058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'CANCER MARKERS' [patent_app_type] => utility [patent_app_number] => 12/576812 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 26359 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152058.pdf [firstpage_image] =>[orig_patent_app_number] => 12576812 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/576812
Cancer markers Oct 8, 2009 Issued
Array ( [id] => 8760267 [patent_doc_number] => 08420788 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Epitopes derived from SATB2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/062820 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 21431 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13062820 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/062820
Epitopes derived from SATB2 and uses thereof Oct 5, 2009 Issued
Array ( [id] => 6485362 [patent_doc_number] => 20100092978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'CADHERIN-17 AS DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR LIVER CANCER' [patent_app_type] => utility [patent_app_number] => 12/569386 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 35688 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092978.pdf [firstpage_image] =>[orig_patent_app_number] => 12569386 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/569386
Cadherin-17 as diagnostic marker and therapeutic target for liver cancer Sep 28, 2009 Issued
Array ( [id] => 6607184 [patent_doc_number] => 20100099102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Development of Diagnostic Markers From the Saliva of Head and Neck Cancer Patients' [patent_app_type] => utility [patent_app_number] => 12/568538 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3417 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099102.pdf [firstpage_image] =>[orig_patent_app_number] => 12568538 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/568538
Development of Diagnostic Markers From the Saliva of Head and Neck Cancer Patients Sep 27, 2009 Abandoned
Array ( [id] => 6376742 [patent_doc_number] => 20100076175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'MOLECULES THAT SELECTIVELY HOME TO VASCULATURE OF PREMALIGNANT OR MALIGNANT LESIONS OF THE PANCREAS AND OTHER ORGANS' [patent_app_type] => utility [patent_app_number] => 12/559305 [patent_app_country] => US [patent_app_date] => 2009-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19558 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076175.pdf [firstpage_image] =>[orig_patent_app_number] => 12559305 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/559305
MOLECULES THAT SELECTIVELY HOME TO VASCULATURE OF PREMALIGNANT OR MALIGNANT LESIONS OF THE PANCREAS AND OTHER ORGANS Sep 13, 2009 Abandoned
Array ( [id] => 9140063 [patent_doc_number] => 08580520 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'YKL-40 as a marker for gastrointestinal cancers' [patent_app_type] => utility [patent_app_number] => 13/063402 [patent_app_country] => US [patent_app_date] => 2009-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 45 [patent_no_of_words] => 50259 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13063402 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/063402
YKL-40 as a marker for gastrointestinal cancers Sep 13, 2009 Issued
Array ( [id] => 6390963 [patent_doc_number] => 20100303715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Prostate-specific membrane antigen and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/584852 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 131 [patent_figures_cnt] => 131 [patent_no_of_words] => 34921 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303715.pdf [firstpage_image] =>[orig_patent_app_number] => 12584852 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/584852
Prostate-specific membrane antigen and uses thereof Sep 10, 2009 Abandoned
Array ( [id] => 10033753 [patent_doc_number] => 09075065 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Prostate cancer biomarker' [patent_app_type] => utility [patent_app_number] => 13/063320 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3568 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13063320 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/063320
Prostate cancer biomarker Sep 9, 2009 Issued
Array ( [id] => 6374871 [patent_doc_number] => 20100081192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'EARLY PROSTATE CANCER ANTIGENS (EPCA), POLYNUCLEOTIDE SEQUENCES ENCODING THEM, AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/550903 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19630 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081192.pdf [firstpage_image] =>[orig_patent_app_number] => 12550903 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/550903
EARLY PROSTATE CANCER ANTIGENS (EPCA), POLYNUCLEOTIDE SEQUENCES ENCODING THEM, AND THEIR USE Aug 30, 2009 Abandoned
Array ( [id] => 6307590 [patent_doc_number] => 20100069470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'IDENTIFICATION OF PROTEIN BIOMARKERS ASSOCIATED WITH LYMPH NODE METASTASIS IN COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 12/551168 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23039 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069470.pdf [firstpage_image] =>[orig_patent_app_number] => 12551168 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/551168
IDENTIFICATION OF PROTEIN BIOMARKERS ASSOCIATED WITH LYMPH NODE METASTASIS IN COLORECTAL CANCER Aug 30, 2009 Abandoned
Menu